mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.01 |
0.7 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |